Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed
where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
本发明揭示了按式(I)和(II)公式的取代
噻唑啉
酮羧酸酰胺和取代
噻唑啉
羧酸酰胺,其中各种取代基团如规范中所定义。还揭示了制备这些化合物的方法,含有这些化合物的药物组合物以及它们的用途,特别是用于治疗或预防癌症。